Eyepoint Inc (EYPT)

Dec 10, 2025

Update Report: Is EyePoint Pharmaceuticals Inc stock positioned for long term growth2025 Biggest Moves & High Accuracy Swing Trade Signals - BỘ NỘI VỤ

Dec 10, 2025

Dec 09, 2025

EyePoint stock maintains Outperform rating at Mizuho amid competitor moves By Investing.com - Investing.com UK

Dec 09, 2025

Dec 09, 2025

EyePoint Pharmaceuticals (EYPT) Maintains Positive Outlook Amid Competitive Dynamics - GuruFocus

Dec 09, 2025

Dec 09, 2025

Walleye Capital LLC Has $1.88 Million Position in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat

Dec 09, 2025

Dec 09, 2025

EyePoint (EYPT) Is Up 25.0% After DURAVYU Phase 3 Safety Green Light And $200M ATM Offering - simplywall.st

Dec 09, 2025

Dec 09, 2025

Federated Hermes Inc. Has $43.28 Million Position in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat

Dec 09, 2025

Dec 09, 2025

Understanding Momentum Shifts in (EYPT) - news.stocktradersdaily.com

Dec 09, 2025

Dec 08, 2025

EyePoint Pharmaceuticals changes name to EyePoint Inc - marketscreener.com

Dec 08, 2025

Dec 08, 2025

EyePoint Pharmaceuticals changes name to EyePoint, Inc., retains EYPT ticker - Investing.com

Dec 08, 2025

Dec 08, 2025

EyePoint Pharmaceuticals Announces Official Name Change - TipRanks

Dec 08, 2025

Dec 08, 2025

EyePoint Pharmaceuticals changes name to EyePoint, Inc., retains EYPT ticker By Investing.com - Investing.com India

Dec 08, 2025

Dec 08, 2025

Citi Remains a Buy on EyePoint Pharmaceuticals (EYPT) - The Globe and Mail

Dec 08, 2025

Dec 06, 2025

EyePoint Pharmaceuticals Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 06, 2025

Dec 05, 2025

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sets New 12-Month HighHere's What Happened - MarketBeat

Dec 05, 2025

Dec 05, 2025

How EyePoint Pharmaceuticals Inc. (PV3B) stock responds to job market shiftsMarket Growth Review & Community Consensus Trade Signals - Newser

Dec 05, 2025

Dec 05, 2025

Can EyePoint Pharmaceuticals Inc. (PV3B) stock deliver strong annual returnsWeekly Trading Summary & Real-Time Volume Trigger Notifications - Newser

Dec 05, 2025

Dec 05, 2025

How buyback programs support EyePoint Pharmaceuticals Inc. (PV3B) stockMarket Risk Report & Smart Investment Allocation Tips - Newser

Dec 05, 2025

Dec 05, 2025

Will EyePoint Pharmaceuticals Inc. stock outperform value stocksQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - Newser

Dec 05, 2025

Dec 04, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at 15.0 USD - Investing.com

Dec 04, 2025

Dec 04, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at 15.0 USD By Investing.com - Investing.com South Africa

Dec 04, 2025

Dec 04, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock outperform energy sector in 2025CPI Data & Weekly Return Optimization Plans - Newser

Dec 04, 2025

Dec 03, 2025

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 03, 2025

Dec 02, 2025

Is EyePoint Pharmaceuticals Inc. (PV3B) stock positioned for secular growthWeekly Earnings Recap & Fast Entry Momentum Alerts - Newser

Dec 02, 2025

Dec 01, 2025

EyePoint Pharmaceuticals: Promising Outlook for Duravyu in Wet AMD Treatment and Strategic Growth Potential - TipRanks

Dec 01, 2025

Dec 01, 2025

EyePoint Pharmaceuticals Director Sells Shares - TradingView

Dec 01, 2025

Nov 30, 2025

XTX Topco Ltd Acquires 94,210 Shares of Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat

Nov 30, 2025

Nov 29, 2025

What drives EyePoint Pharmaceuticals Inc stock priceEvening Star Patterns & Exceptional Return Capital - earlytimes.in

Nov 29, 2025

Nov 28, 2025

Investors Appear Satisfied With EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Prospects As Shares Rocket 26% - 富途牛牛

Nov 28, 2025

Nov 28, 2025

EyePoint Pharmaceuticals (EYPT) Is Up 8.4% After Positive Phase 3 Safety Review for DURAVYU - Sahm

Nov 28, 2025

Nov 28, 2025

Officer/Dir Lurker Files To Sell 500 Of EyePoint Pharmaceuticals Inc [EYPT] - TradingView

Nov 28, 2025

Nov 28, 2025

What analysts say about EyePoint Pharmaceuticals Inc PV3B stockHigh Dividend Yield Stocks & Access Free Risk Analysis Before You Invest - earlytimes.in

Nov 28, 2025

Nov 28, 2025

Avoiding Lag: Real-Time Signals in (EYPT) Movement - news.stocktradersdaily.com

Nov 28, 2025

Nov 27, 2025

EyePoint Pharmaceuticals (EYPT): A Fresh Valuation Look Following Key DURAVYU Phase 3 Safety Review Completion - Sahm

Nov 27, 2025

Nov 27, 2025

Will EyePoint Pharmaceuticals Inc. stock see PE expansionJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Franklin Resources Inc. Buys 151,262 Shares of Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat

Nov 27, 2025

Nov 26, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at $14.94 By Investing.com - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at $14.94 - Investing.com

Nov 26, 2025

Nov 26, 2025

EyePoint receives second consecutive positive recommendation from DSMC - Modern Retina

Nov 26, 2025

Nov 21, 2025

Why Institutions Believe Infibeam Avenues Limited Is Undervalued TodayStock Watchlist Updates & Collaborate and Win Together - earlytimes.in

Nov 21, 2025

Nov 21, 2025

EyePoint Pharmaceuticals (EYPT) Clears Phase 3 Safety Hurdle for DURAVYU—Is a New Wet AMD Era Ahead? - Sahm

Nov 21, 2025

Nov 21, 2025

Can EyePoint Pharmaceuticals Inc. (PV3B) stock sustain double digit ROETrade Risk Report & Detailed Earnings Play Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

EyePoint Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Australia

Nov 21, 2025

Nov 20, 2025

EyePoint Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Nov 20, 2025

Nov 20, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock beat growth indexesExit Point & Daily Technical Forecast Reports - newser.com

Nov 20, 2025